It’s just a matter of time before public outrage will force governments, the US government in the first place, to invest in confronting Zika virus spread.
“Everything we look at with this (Zika) virus seems to be a little scarier than we initially thought,” Dr. Anne Schuchat, CDC principal deputy director, White House briefing, April 11, 2016.
On March 4, 2016, Johns Hopkins and Florida State researchers reported in Cell Stem Cell journal that the Zika virus infects a type of neural stem cell that gives rise to the brain’s cerebral cortex.
On April 13, 2016, the U.S. Centers for Disease Control and Prevention confirmed that the Zika virus causes microcephaly and other birth defects, basing the statement on a special report published by the New England Journal of Medicine.
This studies significantly raise the Zika virus alarm level with far reaching implications. Zika challenge may prove to be on par with AIDS. As the level of alarm over spread of the Zika virus intensifies, governments all over the world, international organizations and pharmaceutical companies race to contain the threat in all its dimensions: vector control, geographical containment, diagnostic test, R&D of vaccines and antivirals, and establishing infrastructures and mechanisms for possible pandemic mitigation.
The global Zika virus preparedness market is expected to reach $4 Billion by 2022 and grow at CAGR 11% in the period 2017-2022.
The report covers the following market segments, products, technologies and services:
- Zika virus preparedness market by geographic regions and major countries;
- Vaccines (including but not limited DNA vaccines, adjuvants);
- Antivirals;
- Diagnostic tests;
- Vector surveillance and control by surveillance, mechanical, chemical, biological and genetic control methods;
- Clinical trials;
- Medical supplies (including but not limited to therapeutics and blood transfusion management);
- Government, state and local preparedness;
- Risk communications;
- R&D spending and funding.
Table of Contents
1. Market Report Scope & Methodology
1.1. Scope
1.2. Research Methodology
2. Key Report findings
3. Product Pipelines
3.1. Diagnostic Pipeline: PCR and Serology Tests
3.2. Therapeutics
3.3. Vaccines
4. Zika Virus Preparedness Market in Numbers
4.1. Zika Virus Preparedness Market by Geographic Region
4.2. Zika Virus Preparedness Market by Segments
4.3. Zika Virus Preparedness: R&D Spending and Funding
List of Tables
Table 1 – Lab based use: nucleic acid test kits
Table 2 – ELISA based tests
Table 3 – RDT type tests
Table 4 – Therapeutics
Table 5 – Vaccines
Table 6 – Global Zika Virus Preparedness Market Forecast 2017-2022, $Mln
Table 7 – Zika Virus Preparedness Market 2017-2022 by Geographic Region, $Mln
Table 8 – Zika Virus Preparedness Market 2017-2022 by Major Countries, $Mln
Table 9 – Zika Virus Preparedness Market 2017-2022 by Segments, $Mln
Table 10 – Zika Virus Preparedness: R&D Spending, $Mln
List of Figures
Fig. 1- Global Zika Virus Preparedness Market Forecast 2017-2022, $Mln
Fig. 2- Cumulative Zika Virus Preparedness Market 2017-2022, Market Share by Regions, %
Fig. 3- Cumulative Zika Virus Preparedness Market 2017-2022 by Major Countries, %
Fig. 4- Zika Virus Preparedness Market 2017-2022 by Geography, $Mln
Fig. 5- Zika Virus Preparedness Market Growth Rates 2017-2022 by Region, CAGR %
Fig. 6- Zika Virus Preparedness Market Dynamics by Geography
Fig. 7- Americas: Zika Virus Preparedness Market Forecast 2017 – 2022, $Mln
Fig. 8- EMEA: Zika Virus Preparedness Market Forecast 2017 – 2022, $Mln
Fig. 9- Asia/Pacific: Zika Virus Preparedness Market Forecast 2017 – 2022, $Mln
Fig. 10- Cumulative Zika Virus Preparedness Market 2017-2022 by Segments, %
Fig. 11- Zika Virus Preparedness: Vaccines Market Forecast 2017 – 2022, $Mln
Fig. 12- Zika Virus Preparedness: Antivirals Market Forecast 2017 – 2022, $Mln
Fig. 13- Zika Virus Preparedness: Diagnostic Tests Market Forecast 2017 – 2022, $Mln
Fig. 14- Zika Virus Preparedness: Vector Surveillance and Control Market Forecast 2017 – 2022, $Mln
Fig. 15- Zika Virus Preparedness: Cumulative Vector Surveillance and Control Market Forecast 2017 – 2022 by Surveillance and Mechanical, Chemical, Biological and Genetic Control Segments
Fig. 16- Zika Virus Preparedness: Clinical Trials Market Forecast 2017 – 2022, $Mln
Fig. 17- Zika Virus Preparedness: Medical Supplies Market Forecast 2017 – 2022, $Mln
Fig. 18- Zika Virus: Government, State and Local Preparedness Market Forecast 2017 – 2022, $Mln
Fig. 19- Zika Virus Preparedness: Risk Communications Market Forecast 2017 – 2022, $Mln
Fig. 20- Zika Virus Preparedness: R&D Spending, $Mln
Fig. 21- Zika Virus Preparedness Funding by Source
